Early research (Phase 1)Study completedNCT00418483
What this trial is testing
A Dose Escalation and Safety Study of Plasmin (Human) In Acute Lower Extremity Native Artery or Bypass Graft Occlusion
Who this might be right for
Arterial Occlusive Diseases
Grifols Therapeutics LLC 83